Anti-Glycation Composition Using Synergistic Plant Extracts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing anti-glycation products for skin do not effectively address skin glycation from the perspective of gene expression, failing to deeply solve the issue of skin aging caused by advanced glycation end products.
Innovation Solution
A composition comprising Osmanthus fragrans extract, Punica granatum extract, and Olea europaea extract, with specific polyphenol and active compound content, which synergistically inhibits the generation of advanced glycation end products, enhances antioxidant capacity, and improves skin metabolism, thereby reducing glycation and increasing anti-glycation ability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing anti-glycation products are used, then skin glycation is addressed superficially, but the deep mechanism of gene expression is not effectively targeted
Solution Approach 1:
The patent combines three different plant extracts (Osmanthus fragrans, Punica granatum, and Olea europaea) into a composite composition, where each extract contributes unique bioactive compounds that work synergistically to inhibit AGEs at the gene expression level, thereby enhancing the reliability of the anti-glycation effect
Solution Approach 2:
The patent specifies precise concentration ranges for each extract (0.1-5 parts Osmanthus fragrans, 0.1-5 parts Punica granatum, 0.1-2 parts Olea europaea) to optimize the inhibition of AGEs gene expression while maintaining skin safety and efficacy
2Reliability
If multiple plant extracts are combined to enhance anti-glycation effect, then the inhibition of AGEs generation is improved, but the formulation complexity increases
Solution Approach 1:
The patent creates a composite formulation combining three plant extracts with complementary mechanisms: Osmanthus fragrans (verbascoside), Punica granatum (punicalagin), and Olea europaea (hydroxytyrosol), achieving enhanced AGEs inhibition through synergistic interactions while maintaining a relatively simple overall formulation structure
Solution Approach 2:
Each plant extract in the composition serves multiple functions: they all inhibit AGEs generation, provide antioxidant protection, and improve skin metabolism, thereby reducing the need for additional separate ingredients and simplifying the overall formulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly reduces the generation of advanced glycation end products and improves skin brightness, elasticity, and antioxidant defenses, effectively addressing skin glycation and aging through a three-dimensional anti-glycation mechanism.
Implementation Method 1
the verbascoside in the Osmanthus fragrans extract can inhibit the generation of AGEs (advanced glycation end products)
Implementation Method 2
polyphenol substances have the effects of resisting oxidation, scavenging free radicals
Implementation Method 3
the punicalagin in the Punica granatum extract can also inhibit the generation of AGEs, and also has the effects of preventing a protein structure from being glycated and destroyed
Implementation Method 4
the hydroxytyrosol in the Olea europaea extract can enhance antioxidant capacity; when the content of the hydroxytyrosol is more than or equal to 10%, the hydroxytyrosol can significantly enhance antioxidant effect, inhibit oxidation of primary glycation products to form AGEs
Data Source
AI summary
The present invention relates to a composition having an anti-glycation effect and an application thereof. The anti-glycation composition includes the following constituents in parts by mass: 0.1 to 5 parts of Osmanthus fragrans extract, 0.1 to 5 parts of Punica granatum extract and 0.1 to 2 part of Olea europaea extract, wherein in the Osmanthus fragrans extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of verbascoside is more than or equal to 10%; in the Punica granatum extract, a mass content of polyphenol is more than or equal to 30%, and a mass content of punicalagin is more than or equal to 8%; and in the Olea europaea extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of hydroxytyrosol is more than or equal to 3%.